GO:1901576 | organic substance biosynthetic process | 48.87% (65/133) | 4.14 | 0.0 | 0.0 |
GO:0034645 | cellular macromolecule biosynthetic process | 45.11% (60/133) | 4.68 | 0.0 | 0.0 |
GO:1901566 | organonitrogen compound biosynthetic process | 45.11% (60/133) | 4.45 | 0.0 | 0.0 |
GO:0043226 | organelle | 42.86% (57/133) | 4.42 | 0.0 | 0.0 |
GO:0043228 | non-membrane-bounded organelle | 42.86% (57/133) | 4.7 | 0.0 | 0.0 |
GO:0043229 | intracellular organelle | 42.86% (57/133) | 4.43 | 0.0 | 0.0 |
GO:0043232 | intracellular non-membrane-bounded organelle | 42.86% (57/133) | 4.7 | 0.0 | 0.0 |
GO:0043603 | amide metabolic process | 44.36% (59/133) | 4.69 | 0.0 | 0.0 |
GO:0043604 | amide biosynthetic process | 44.36% (59/133) | 4.74 | 0.0 | 0.0 |
GO:0044237 | cellular metabolic process | 52.63% (70/133) | 3.24 | 0.0 | 0.0 |
GO:0044249 | cellular biosynthetic process | 47.37% (63/133) | 4.17 | 0.0 | 0.0 |
GO:0044260 | cellular macromolecule metabolic process | 45.11% (60/133) | 4.36 | 0.0 | 0.0 |
GO:0044271 | cellular nitrogen compound biosynthetic process | 46.62% (62/133) | 4.42 | 0.0 | 0.0 |
GO:0034641 | cellular nitrogen compound metabolic process | 47.37% (63/133) | 3.96 | 0.0 | 0.0 |
GO:0019538 | protein metabolic process | 45.86% (61/133) | 3.53 | 0.0 | 0.0 |
GO:0003735 | structural constituent of ribosome | 44.36% (59/133) | 4.75 | 0.0 | 0.0 |
GO:0005198 | structural molecule activity | 44.36% (59/133) | 4.68 | 0.0 | 0.0 |
GO:0005840 | ribosome | 42.86% (57/133) | 4.76 | 0.0 | 0.0 |
GO:0006412 | translation | 44.36% (59/133) | 4.75 | 0.0 | 0.0 |
GO:0006518 | peptide metabolic process | 44.36% (59/133) | 4.71 | 0.0 | 0.0 |
GO:0043043 | peptide biosynthetic process | 44.36% (59/133) | 4.74 | 0.0 | 0.0 |
GO:0009059 | macromolecule biosynthetic process | 45.11% (60/133) | 4.51 | 0.0 | 0.0 |
GO:0008152 | metabolic process | 56.39% (75/133) | 2.87 | 0.0 | 0.0 |
GO:0009058 | biosynthetic process | 50.38% (67/133) | 4.09 | 0.0 | 0.0 |
GO:0110165 | cellular anatomical entity | 46.62% (62/133) | 3.35 | 0.0 | 0.0 |
GO:0005575 | cellular_component | 48.87% (65/133) | 3.15 | 0.0 | 0.0 |
GO:0009987 | cellular process | 55.64% (74/133) | 2.8 | 0.0 | 0.0 |
GO:0043170 | macromolecule metabolic process | 47.37% (63/133) | 3.24 | 0.0 | 0.0 |
GO:1901564 | organonitrogen compound metabolic process | 46.62% (62/133) | 3.28 | 0.0 | 0.0 |
GO:0006807 | nitrogen compound metabolic process | 48.87% (65/133) | 3.11 | 0.0 | 0.0 |
GO:0044238 | primary metabolic process | 50.38% (67/133) | 2.93 | 0.0 | 0.0 |
GO:0071704 | organic substance metabolic process | 51.13% (68/133) | 2.87 | 0.0 | 0.0 |
GO:0008150 | biological_process | 60.15% (80/133) | 2.37 | 0.0 | 0.0 |
GO:0003674 | molecular_function | 69.17% (92/133) | 1.73 | 0.0 | 0.0 |
GO:0003723 | RNA binding | 9.02% (12/133) | 3.06 | 0.0 | 0.0 |
GO:0006413 | translational initiation | 3.76% (5/133) | 5.32 | 0.0 | 1e-06 |
GO:0090079 | translation regulator activity, nucleic acid binding | 4.51% (6/133) | 4.47 | 0.0 | 2e-06 |
GO:0045182 | translation regulator activity | 4.51% (6/133) | 4.47 | 0.0 | 2e-06 |
GO:0008135 | translation factor activity, RNA binding | 4.51% (6/133) | 4.47 | 0.0 | 2e-06 |
GO:0003676 | nucleic acid binding | 11.28% (15/133) | 1.98 | 7e-06 | 4.5e-05 |
GO:0003743 | translation initiation factor activity | 3.01% (4/133) | 4.73 | 1.7e-05 | 0.000108 |
GO:0009922 | fatty acid elongase activity | 1.5% (2/133) | 6.8 | 0.000135 | 0.000851 |
GO:1901363 | heterocyclic compound binding | 15.79% (21/133) | 1.24 | 0.000205 | 0.001227 |
GO:0097159 | organic cyclic compound binding | 15.79% (21/133) | 1.24 | 0.000205 | 0.001227 |
GO:0004312 | fatty acid synthase activity | 1.5% (2/133) | 6.44 | 0.000231 | 0.001357 |
GO:0005488 | binding | 21.8% (29/133) | 0.9 | 0.000627 | 0.003598 |
GO:0044391 | ribosomal subunit | 1.5% (2/133) | 5.36 | 0.001081 | 0.005944 |
GO:0015934 | large ribosomal subunit | 1.5% (2/133) | 5.36 | 0.001081 | 0.005944 |
GO:0043022 | ribosome binding | 1.5% (2/133) | 5.02 | 0.00173 | 0.00932 |
GO:0006417 | regulation of translation | 1.5% (2/133) | 4.97 | 0.001877 | 0.00935 |
GO:0010608 | post-transcriptional regulation of gene expression | 1.5% (2/133) | 4.97 | 0.001877 | 0.00935 |
GO:0034248 | regulation of amide metabolic process | 1.5% (2/133) | 4.97 | 0.001877 | 0.00935 |
GO:2000112 | regulation of cellular macromolecule biosynthetic process | 1.5% (2/133) | 4.97 | 0.001877 | 0.00935 |
GO:0043021 | ribonucleoprotein complex binding | 1.5% (2/133) | 4.91 | 0.00203 | 0.009925 |
GO:0005845 | mRNA cap binding complex | 0.75% (1/133) | 8.61 | 0.00256 | 0.010559 |
GO:0034518 | RNA cap binding complex | 0.75% (1/133) | 8.61 | 0.00256 | 0.010559 |
GO:0001653 | peptide receptor activity | 0.75% (1/133) | 8.61 | 0.00256 | 0.010559 |
GO:0060089 | molecular transducer activity | 0.75% (1/133) | 8.61 | 0.00256 | 0.010559 |
GO:0038023 | signaling receptor activity | 0.75% (1/133) | 8.61 | 0.00256 | 0.010559 |
GO:0016503 | pheromone receptor activity | 0.75% (1/133) | 8.61 | 0.00256 | 0.010559 |
GO:0004932 | mating-type factor pheromone receptor activity | 0.75% (1/133) | 8.61 | 0.00256 | 0.010559 |
GO:0004930 | G protein-coupled receptor activity | 0.75% (1/133) | 8.61 | 0.00256 | 0.010559 |
GO:0004888 | transmembrane signaling receptor activity | 0.75% (1/133) | 8.61 | 0.00256 | 0.010559 |
GO:0008528 | G protein-coupled peptide receptor activity | 0.75% (1/133) | 8.61 | 0.00256 | 0.010559 |
GO:0044877 | protein-containing complex binding | 1.5% (2/133) | 4.57 | 0.00326 | 0.01324 |
GO:0019843 | rRNA binding | 1.5% (2/133) | 4.36 | 0.004304 | 0.017217 |
GO:0003922 | GMP synthase (glutamine-hydrolyzing) activity | 0.75% (1/133) | 7.61 | 0.005113 | 0.017761 |
GO:0042255 | ribosome assembly | 0.75% (1/133) | 7.61 | 0.005113 | 0.017761 |
GO:0008612 | peptidyl-lysine modification to peptidyl-hypusine | 0.75% (1/133) | 7.61 | 0.005113 | 0.017761 |
GO:2000113 | negative regulation of cellular macromolecule biosynthetic process | 0.75% (1/133) | 7.61 | 0.005113 | 0.017761 |
GO:0034249 | negative regulation of amide metabolic process | 0.75% (1/133) | 7.61 | 0.005113 | 0.017761 |
GO:0042256 | cytosolic ribosome assembly | 0.75% (1/133) | 7.61 | 0.005113 | 0.017761 |
GO:0046037 | GMP metabolic process | 0.75% (1/133) | 7.61 | 0.005113 | 0.017761 |
GO:0006177 | GMP biosynthetic process | 0.75% (1/133) | 7.61 | 0.005113 | 0.017761 |
GO:0017148 | negative regulation of translation | 0.75% (1/133) | 7.61 | 0.005113 | 0.017761 |
GO:0003746 | translation elongation factor activity | 1.5% (2/133) | 4.25 | 0.004995 | 0.019683 |
GO:0051246 | regulation of protein metabolic process | 1.5% (2/133) | 4.02 | 0.006792 | 0.023287 |
GO:0019673 | GDP-mannose metabolic process | 0.75% (1/133) | 7.02 | 0.00766 | 0.024364 |
GO:0009225 | nucleotide-sugar metabolic process | 0.75% (1/133) | 7.02 | 0.00766 | 0.024364 |
GO:0004615 | phosphomannomutase activity | 0.75% (1/133) | 7.02 | 0.00766 | 0.024364 |
GO:0009226 | nucleotide-sugar biosynthetic process | 0.75% (1/133) | 7.02 | 0.00766 | 0.024364 |
GO:0009298 | GDP-mannose biosynthetic process | 0.75% (1/133) | 7.02 | 0.00766 | 0.024364 |
GO:1901362 | organic cyclic compound biosynthetic process | 3.01% (4/133) | 2.4 | 0.007239 | 0.024502 |
GO:1990904 | ribonucleoprotein complex | 1.5% (2/133) | 3.91 | 0.007931 | 0.024926 |
GO:0055086 | nucleobase-containing small molecule metabolic process | 2.26% (3/133) | 2.73 | 0.01078 | 0.033481 |
GO:0004749 | ribose phosphate diphosphokinase activity | 0.75% (1/133) | 6.29 | 0.012734 | 0.036943 |
GO:0016126 | sterol biosynthetic process | 0.75% (1/133) | 6.29 | 0.012734 | 0.036943 |
GO:0031327 | negative regulation of cellular biosynthetic process | 0.75% (1/133) | 6.29 | 0.012734 | 0.036943 |
GO:0016125 | sterol metabolic process | 0.75% (1/133) | 6.29 | 0.012734 | 0.036943 |
GO:0010558 | negative regulation of macromolecule biosynthetic process | 0.75% (1/133) | 6.29 | 0.012734 | 0.036943 |
GO:0009890 | negative regulation of biosynthetic process | 0.75% (1/133) | 6.29 | 0.012734 | 0.036943 |
GO:0140694 | non-membrane-bounded organelle assembly | 0.75% (1/133) | 6.02 | 0.015262 | 0.043323 |
GO:0051248 | negative regulation of protein metabolic process | 0.75% (1/133) | 6.02 | 0.015262 | 0.043323 |
GO:0005506 | iron ion binding | 2.26% (3/133) | 2.52 | 0.015945 | 0.044781 |
GO:0034654 | nucleobase-containing compound biosynthetic process | 2.26% (3/133) | 2.51 | 0.016151 | 0.044882 |
GO:0009127 | purine nucleoside monophosphate biosynthetic process | 0.75% (1/133) | 5.8 | 0.017783 | 0.045141 |
GO:0009156 | ribonucleoside monophosphate biosynthetic process | 0.75% (1/133) | 5.8 | 0.017783 | 0.045141 |
GO:0009161 | ribonucleoside monophosphate metabolic process | 0.75% (1/133) | 5.8 | 0.017783 | 0.045141 |
GO:0009167 | purine ribonucleoside monophosphate metabolic process | 0.75% (1/133) | 5.8 | 0.017783 | 0.045141 |
GO:0009123 | nucleoside monophosphate metabolic process | 0.75% (1/133) | 5.8 | 0.017783 | 0.045141 |
GO:0009126 | purine nucleoside monophosphate metabolic process | 0.75% (1/133) | 5.8 | 0.017783 | 0.045141 |
GO:0070925 | organelle assembly | 0.75% (1/133) | 5.8 | 0.017783 | 0.045141 |
GO:0009168 | purine ribonucleoside monophosphate biosynthetic process | 0.75% (1/133) | 5.8 | 0.017783 | 0.045141 |
GO:0009124 | nucleoside monophosphate biosynthetic process | 0.75% (1/133) | 5.8 | 0.017783 | 0.045141 |
GO:0016778 | diphosphotransferase activity | 0.75% (1/133) | 5.61 | 0.020297 | 0.048713 |
GO:0016628 | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor | 0.75% (1/133) | 5.61 | 0.020297 | 0.048713 |
GO:0016868 | intramolecular transferase activity, phosphotransferases | 0.75% (1/133) | 5.61 | 0.020297 | 0.048713 |
GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor | 0.75% (1/133) | 5.61 | 0.020297 | 0.048713 |
GO:1901137 | carbohydrate derivative biosynthetic process | 1.5% (2/133) | 3.18 | 0.020662 | 0.049141 |